March 2024

FORT LEE, N.J., March 2, 2024 /PRNewswire/ — Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan Udenafil Exercise Longitudinal Assessment Trial- 2, or FUEL-2 trial. The company is pleased to announce Dr. R

MEXICO CITY, March 1, 2024 /PRNewswire/ — TRUST 7401, a trust formed under the laws of the United Mexican States (“NEXT Properties” or the “New Issuer”) hereby announces the extension of the Expiration Date of the four separate offers to exchange announced on November 1

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: